The biotech sector witnessed a see-saw performance in 2024. While the year started on a positive note, much of the gains ...

Its product candidate, TP-03, is a novel therapeutic in Phase 2b/3 that is being developed for the treatment of blepharitis caused by the infestation of Demodex mites, which is referred to as ...

Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS – Get Free Report) has been assigned a consensus recommendation of “Buy” from the ...

Eyelash dandruff, though often underestimated, has the potential to disrupt your eye health and overall well-being. Vigilance ...